Show items per page
Elements: 25
Page 1 on 2
 TitleAuthors / EditorsDate
add to browser selection
Residual risk of liver disease after hepatitis C virus eradication Negro, Francesco 2021
add to browser selection
Shorter survival after liver pedicle clamping in patients undergoing liver resection for hepatocellular carcinoma revealed by a systematic review and meta-analysis Wassmer, Charles-Henri; Moeckli, Beat; Berney, Thierry; Toso, Christian; Orci, Lorenzo 2021
add to browser selection
Assessing the impact of COVID-19 on liver cancer management (CERO-19) Muñoz-Martínez, Sergio; Sapena, Victor; Forner, Alejandro; Nault, Jean-Charles; ... Reig, Maria 2021
add to browser selection
Management of hepatocellular carcinoma: SASL expert opinion statement Goossens, Nicolas; Toso, Christian; Heim, Markus H 2020
add to browser selection
Should we use liver grafts repeatedly refused by other transplant teams? Winter, Audrey; Landais, Paul; Azoulay, Daniel; Disabato, Mara; ... Féray, Cyrille 2020
add to browser selection
Liver transplantation for hepatocellular carcinoma after successful treatment of macrovascular invasion Assalino, Michela; Terraz, Sylvain; Grat, Michal; Lai, Quirino; ... Toso, Christian 2020
add to browser selection
mRNA post-transcriptional regulation by AU-rich element-binding proteins in liver inflammation and cancer Dolicka, Dobrochna; Sobolewski, Cyril; Correia De Sousa, Marta; Gjorgjieva, Monika; Foti, Michelangelo 2020
add to browser selection
S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development Sobolewski, Cyril; Abegg, Daniel; Berthou, Flavien; Dolicka, Dobrochna; ... Foti, Michelangelo 2020
add to browser selection
Recent developments and ongoing trials in transplant oncology Moeckli, Beat; Ivanics, Tommy; Claasen, Marco; Toso, Christian; Sapisochin, Gonzalo 2020
add to browser selection
Contribution of big data to biomarker and therapeutic discovery in liver disease Goossens, Nicolas 2019
add to browser selection
Liver immune microenvironment from normal liver to hepatocellular carcinoma Lacotte, Stéphanie 2019
add to browser selection
Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland Blach, Sarah; Schaetti, Christian; Bruggmann, Philip; Negro, Francesco; Razavi, Homie 2019
add to browser selection
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030? Müllhaupt, Beat; Bruggmann, Philip; Bihl, Florian; Blach, Sarah; ... Negro, Francesco 2018
add to browser selection
Fecal microbiota transplantation: a promising strategy in preventing the progression of non-alcoholic steatohepatitis and improving the anti-cancer immune response Delaune, Vaihere; Orci, Lorenzo; Lacotte, Stéphanie; Peloso, Andréa; ... Toso, Christian 2018
add to browser selection
BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease Oussalah, Abderrahim; Avogbe, Patrice Hodonou 2017
add to browser selection
mTORC2 Promotes Tumorigenesis via Lipid Synthesis Guri, Yakir; Colombi, Marco; Dazert, Eva; Hindupur, Sravanth K.; ... Hall, Michael N. 2017
add to browser selection
Anti-angiogenic strategies for chemoembolization of liver tumors Fuchs, Katrin 2016
add to browser selection
Endobiliary hepatocellular carcinoma: A rare tumor mimicking cholangiocarcinoma Hansen, Catrina; Ronot, Maxime; Toso, Christian; Rubbia-Brandt, Laura; ... Terraz, Sylvain 2016
add to browser selection
Insights into the diagnosis of hepatocellular carcinomas with hepatobiliary MRI Vilgrain, Valérie; Van Beers, Bernard E; Pastor, Catherine 2016
add to browser selection
Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease Sanchez, Andréa; Clement, Sophie; Peyrou, Marion; Spahr, Laurent François Joséph; ... Foti, Michelangelo 2016
<< previous | 1 | 2 |